Revitalid Pharmaceutical Corp.

Name | Role | Address |
---|---|---|
CORPORATION SERVICE COMPANY | Agent | 222 JEFFERSON BOULEVARD SUITE 200, WARWICK, RI, 02888, USA |
Name | Role | Address |
---|---|---|
CHRISTOPHER KLEIN | SECRETARY | 400 CROSSING BLVD, BRIDGEWATER, NJ 08807 USA |
Name | Role | Address |
---|---|---|
BRIAN MARKISON | CEO | 400 CROSSING BLVD BRIDGEWATER, NJ 08807 USA |
Name | Role | Address |
---|---|---|
ANDREW EINHORN | CFO | 400 CROSSING BLVD, BRIDGEWATER, NJ 08807 USA |
Name | Role | Address |
---|---|---|
BRIAN MARKISON | DIRECTOR | 400 CROSSING BLVD BRIDGEWATER, NJ 08807 USA |
CARLOS SIELECKI | DIRECTOR | 400 CROSSING BLVD BRIDGEWATER, NJ 08807 USA |
DANIEL SIELECKI | DIRECTOR | 400 CROSSING BLVD, BRIDGEWATER, NJ 08807 USA |
JUAN VERGEZ | DIRECTOR | 400 CROSSING BLVD BRIDGEWATER, NJ 08807 USA |
SRIRAM VENKATARAMAN | DIRECTOR | 400 CROSSING BLVD BRIDGEWATER, NJ 08807 USA |
DAVID BURGSTAHLER | DIRECTOR | 65 EAST 55TH STREET,18TH FLOOR NEW YORK, NY 10022 USA |
Type | Date | Old Value | New Value |
---|---|---|---|
Name Change | 2023-04-18 | Osmotica Pharmaceutical Corp. | Revitalid Pharmaceutical Corp. |
Number | Name | File Date |
---|---|---|
202459587510 | Revocation Certificate For Failure to File the Annual Report for the Year | 2024-09-17 |
202457269300 | Revocation Notice For Failure to File An Annual Report | 2024-06-25 |
202334284060 | Annual Report | 2023-04-27 |
202333227310 | Application for Amended Certificate of Authority | 2023-04-18 |
202218679210 | Annual Report | 2022-06-21 |
This company hasn't received any reviews.
Date of last update: 16 Jul 2025
Sources: Rhode Island Department of State